These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35350548)

  • 1. Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness.
    Li KQ; Shi X; Miao W; Tchetgen ET
    ArXiv; 2023 Mar; ():. PubMed ID: 35350548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Biases in Test-Negative Design Studies of COVID-19 Vaccine Effectiveness Arising from the Inclusion of Asymptomatic Individuals.
    Ortiz-Brizuela E; Carabali M; Jiang C; Merckx J; Talbot D; Schnitzer ME
    Am J Epidemiol; 2024 Aug; ():. PubMed ID: 39160637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design.
    Haber M; Lopman BA; Tate JE; Shi M; Parashar UD
    Vaccine; 2019 May; 37(24):3229-3233. PubMed ID: 31036459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Ainslie KEC; Shi M; Haber M; Orenstein WA
    Vaccine; 2017 Dec; 35(52):7297-7301. PubMed ID: 29146382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo.
    Pearson CAB; Edmunds WJ; Hladish TJ; Eggo RM
    Int J Epidemiol; 2022 Feb; 51(1):265-278. PubMed ID: 34458913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.
    Foppa IM; Ferdinands JM; Chaves SS; Haber MJ; Reynolds SB; Flannery B; Fry AM
    Int J Epidemiol; 2016 Dec; 45(6):2052-2059. PubMed ID: 26979985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review.
    Mésidor M; Liu Y; Talbot D; Skowronski DM; De Serres G; Merckx J; Koushik A; Tadrous M; Carazo S; Jiang C; Schnitzer ME
    Vaccine; 2024 Feb; 42(5):995-1003. PubMed ID: 38072756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothesis testing and sample size considerations for the test-negative design.
    Huo Y; Yang Y; Halloran ME; Longini IM; Dean NE
    BMC Med Res Methodol; 2024 Jul; 24(1):151. PubMed ID: 39014324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiply robust causal inference with double-negative control adjustment for categorical unmeasured confounding.
    Shi X; Miao W; Nelson JC; Tchetgen EJT
    J R Stat Soc Series B Stat Methodol; 2020 Apr; 82(2):521-540. PubMed ID: 33376449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesis testing and sample size considerations for the test-negative design.
    Huo Y; Yang Y; Halloran ME; Longini IM; Dean NE
    Res Sq; 2023 Dec; ():. PubMed ID: 38234799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design.
    Schwartz LM; Halloran ME; Rowhani-Rahbar A; Neuzil KM; Victor JC
    Vaccine; 2017 Jan; 35(1):184-190. PubMed ID: 27876198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial.
    Zhang L; Jin P; Wei M; Jiang H; Li J; Zhu F
    Hum Vaccin Immunother; 2022 Nov; 18(5):2073751. PubMed ID: 35678636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of a test-negative design for EV-71 vaccine from a randomized controlled trial.
    Zhang L; Wei M; Jin P; Li J; Zhu F
    Hum Vaccin Immunother; 2021 Jul; 17(7):2101-2106. PubMed ID: 33529093
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of Recently Vaccinated Individuals to Detect Bias in Test-Negative Case-Control Studies of COVID-19 Vaccine Effectiveness.
    Hitchings MDT; Lewnard JA; Dean NE; Ko AI; Ranzani OT; Andrews JR; Cummings DAT
    Epidemiology; 2022 Jul; 33(4):450-456. PubMed ID: 35384900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case test-negative design for studies of the effectiveness of influenza vaccine.
    Foppa IM; Haber M; Ferdinands JM; Shay DK
    Vaccine; 2013 Jun; 31(30):3104-9. PubMed ID: 23624093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.
    Sullivan SG; Tchetgen Tchetgen EJ; Cowling BJ
    Am J Epidemiol; 2016 Sep; 184(5):345-53. PubMed ID: 27587721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and the epistemology of epidemiological models at the dawn of AI.
    Ellison GTH
    Ann Hum Biol; 2020 Sep; 47(6):506-513. PubMed ID: 33228409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.